How Advances in CLL Treatment Are Building Momentum

Treatment for chronic lymphocytic leukemia (CLL) has come a long way. For years, doctors relied primarily on chemotherapy. But advances in research have given them entirely new ways to fight the disease including by interfering with proteins that cancer needs.¹

The growing list of treatment options has made it possible for doctors to personalize care. To determine the most promising strategy for each person diagnosed with CLL, doctors evaluate their risk factors, such as age and other health conditions.² They also consider the genetic profile and other features of someone’s disease.³

This approach is designed to make a difference by giving many people with CLL the potential chance to live longer with a better quality of life.⁴ Meanwhile, research is still moving forward, with new therapies on the way.⁵

As the maker of foundational medicines for CLL and other blood cancers, BeOne Medicines knows more progress is possible. That’s why we continue to push forward — to bring new, potentially transformative therapies to more people around the world.

Swipe below to learn more about how treatment for this cancer continues to change. Or, download the full timeline here.